2024 American Academy of Neurology Abstract Website

Disclosures for "A Brain Care Score for Risk of Late-life Depression: Data from the UK Biobank Cohort "

Dr. Singh has nothing to disclose.
Dr. Rivier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyxis Partners.
Mr. Oreskovic has nothing to disclose.
Mr. Carr has nothing to disclose.
Dr. Papier has nothing to disclose.
Dr. Chemali has nothing to disclose.
The institution of Dr. Gutierrez-Martinez has received research support from American Heart Association.
Dr. Mallick has nothing to disclose.
Dr. Parodi has nothing to disclose.
Dr. Mayerhofer has nothing to disclose.
Dr. Senff has nothing to disclose.
Christina Kourkoulis has nothing to disclose.
Mr. Clocchiatti-Tuozzo has nothing to disclose.
Dr. Newhouse has nothing to disclose.
Dr. Westover has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
The institution of Dr. Pikula has received research support from CIHR.
Sarah Ibrahim has nothing to disclose.
Dr. Brouwers has nothing to disclose.
The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Dr. Yechoor has nothing to disclose.
Prof. Van Duijn has nothing to disclose.
Dr. Littlejohns has nothing to disclose.
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Dr. Fricchione has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Belvoir Publishing. Dr. Fricchione has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Publishing. Dr. Fricchione has stock in Revival Therapeutics. The institution of Dr. Fricchione has received research support from NIMH. Dr. Fricchione has received intellectual property interests from a discovery or technology relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care. Dr. Fricchione has received publishing royalties from a publication relating to health care.
The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.